Cetera Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Cetera Advisors LLC

$0
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $2.2 Million - $2.4 Million	5,390 Added 63.25%	13,912 $5.82 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $537,824 - $643,946	1,568 Added 22.55%	8,522 $3.47 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $67,974 - $72,854	-201 Reduced 2.81%	6,954 $2.42 Million
Q2 2023 Aug 09, 2023	BUY	$314.42 - $351.91 $66,657 - $74,604	212 Added 3.05%	7,155 $2.52 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $587,985 - $670,755	-2,076 Reduced 23.02%	6,943 $2.19 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $288,617 - $324,694	1,010 Added 12.61%	9,019 $2.6 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $817,382 - $912,007	2,985 Added 59.41%	8,009 $2.32 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $67,433 - $83,961	-287 Reduced 5.4%	5,024 $1.42 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $21,034 - $24,792	95 Added 1.82%	5,311 $1.39 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $2.25 Million - $2.85 Million	-12,737 Reduced 70.95%	5,216 $1.15 Million
Q3 2021 Nov 16, 2021	SELL	$181.39 - $202.99 $1.83 Million - $2.05 Million	-10,104 Reduced 36.01%	17,953 $3.26 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $4.34 Million - $5.12 Million	23,172 Added 474.35%	28,057 $5.66 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $8,694 - $10,135	42 Added 0.87%	4,885 $1.05 Million
Q4 2020 Feb 17, 2021	BUY	$207.01 - $276.09 $132,900 - $177,249	642 Added 15.28%	4,843 $1.15 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $3,834 - $4,546	-15 Reduced 0.36%	4,201 $1.14 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $378,355 - $496,352	1,678 Added 66.12%	4,216 $1.22 Million
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $18,378 - $22,798	92 Added 3.76%	2,538 $604,000
Q4 2019 Feb 10, 2020	BUY	$166.71 - $223.91 $3,000 - $4,030	18 Added 0.74%	2,446 $533,000
Q3 2019 Nov 06, 2019	BUY	$166.23 - $187.09 $1,329 - $1,496	8 Added 0.33%	2,428 $412,000
Q2 2019 Aug 12, 2019	SELL	$164.61 - $190.37 $14,979 - $17,323	-91 Reduced 3.62%	2,420 $445,000
Q1 2019 May 06, 2019	BUY	$163.73 - $194.7 $19,483 - $23,169	119 Added 4.97%	2,511 $462,000
Q4 2018 Feb 15, 2019	SELL	$151.91 - $192.21 $217,231 - $274,860	-1,430 Reduced 37.41%	2,392 $397,000
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $107,514 - $123,546	641 Added 20.15%	3,822 $739,000
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $582 - $679	4 Added 0.13%	3,181 $541,000
Q1 2018 May 09, 2018	BUY	$151.6 - $177.13 $481,633 - $562,742	3,177 New	3,177 $517,000

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.8 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.9 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$11 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$6.06 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.41 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.

Account